Malartan Hct

Valsartan/Hydrochlorothiazide, the active ingredient in Malartan Hct, is an Angiotensin II receptor blocker (ARB) / Thiazide diuretic combination presented as an oral tablet for oral use. It is employed to lower elevated blood pressure in adult patients with hypertension. The formulation combines a vasodilating agent with a diuretic to achieve sustained blood pressure control and reduce cardiovascular risk.

GNH USA supplies Malartan Hct as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures reliable delivery and regulatory compliance across multiple regions.

Malartan Hct, a fixed‑dose antihypertensive combination, is used to manage conditions related to high blood pressure. - Hypertension: lowers systolic and diastolic blood pressure, helping achieve target levels. - Hypertensive‑related edema: promotes diuresis to reduce fluid accumulation associated with elevated pressure. - Cardiovascular risk reduction in hypertensive patients: contributes to decreased risk of stroke and myocardial infarction when used as part of comprehensive therapy.

Common and serious adverse reactions have been reported with the Valsartan/Hydrochlorothiazide combination.

Common Side Effects: - Dizziness: light‑headed sensation, especially on standing. - Headache: mild to moderate pain. - Increased urination: due to the diuretic component. - Fatigue: general tiredness.

Serious or Rare Side Effects: - Hyperkalemia: elevated potassium that may affect cardiac rhythm. - Acute kidney injury: sudden decline in renal function. - Severe hypotension: marked drop in blood pressure causing faintness.

When prescribing Malartan Hct, clinicians should consider several precautionary measures to ensure safe use. - Renal function: assess baseline kidney function and monitor periodically. - Electrolytes: check serum potassium and sodium before initiation and during therapy. - Concomitant diuretics: avoid excessive diuresis when combined with other diuretics. - Pregnancy: avoid use unless clearly needed, as safety data are limited. - Elderly patients: start at lower dose and monitor for orthostatic hypotension. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Malartan Hct may interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - ACE inhibitors or other ARBs: risk of additive hyperkalemia and renal impairment. - Lithium: increased lithium levels leading to toxicity. - NSAIDs: may reduce antihypertensive effect and impair renal function.

Moderate Interactions (Monitor Closely): - Potassium‑sparing diuretics or supplements: monitor serum potassium. - Antidiabetic agents: may enhance hypoglycemic effect. - Cyclosporine or tacrolimus: may increase serum concentrations of Valsartan.